Home
About
Technology
Contact
Energy Fuels and Radtran announce Strategic Alliance
July 29, 2021
Read the full press release:
Press Release
Link
Recent Announcements
Energy Fuels Acquires RadTran LLC as A Further Step Toward Addressing the Global Industry Need For Medical Radioisotopes in Emerging Cancer Treatments.
August 19, 2024
Acquisition intended to enhance Energy Fuels' current capabilities and support announced plans for medical isotope development.
National Cancer Institute Grant Awarded
September 21, 2021
RadTran has been awarded a SBIR Phase I research grant from the National Institute of Health (NIH) and National Cancer Institute (NCI)
DOE STTR Award
January 6, 2020
RadTran has received a Phase I STTR award from the United States Department of Energy to support commercialization of its Ra-228 production process as a means for supporting Ac-225 isotope needs.
Export License and End User Agreement
July 1, 2019
RadTran has been awarded an Export License and End User Agreement by the French government to exchange thorium currently held by its partner Solvay. The first shipment of thorium is expected in early 2020 to support final proof of concept and scalability testing for the RadTran process. All experimental work is being conducted at the Pacific Northwest National Laboratory.
